Evaluation of Topical Riboflavin Exposed to UVA Radiation and Implantation of Corneal Ring

Sponsor
Federal University of São Paulo (Other)
Overall Status
Completed
CT.gov ID
NCT00832897
Collaborator
(none)
31
1
2
31
1

Study Details

Study Description

Brief Summary

The purpose of this study is to postpone the corneal transplantation in keratoconus and promote the stiffness of the cornea across the riboflavin-UVA corneal collagen crosslinking , and after, corneal ring surgery.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Corneal collagen crosslinking
N/A

Detailed Description

Keratoconus is a progressive disease where cornea is thin and has a higher curvature.In early conditions, it may be corrected by glasses or contact lens.When these possibilities are not more possibles, it may be corrected by corneal ring surgery ore corneal transplantation depending your degree.

In this study, the patients with a degree of keratoconus on I or II, will be submitted to corneal collagen crosslinking and then a corneal ring surgery.

The corneal collagen crosslinking promote the stiffness of the cornea across the riboflavin-UVA irradiation, avoid the progression of the keratoconus.After three months of crosslinking, these patients will be submitted a corneal ring surgery.

These patients will be allowed by two years and various exams will realized them.

Study Design

Study Type:
Interventional
Actual Enrollment :
31 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
"Evaluation of Topical Riboflavin Exposed to UVA Radiation and Implantation of Intrastromal Corneal Ring for Treatment of Keratoconus and Others Irregulars Astigmatisms."
Study Start Date :
Mar 1, 2008
Actual Primary Completion Date :
Nov 1, 2008
Actual Study Completion Date :
Oct 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Sham Comparator: Eyedrop

Procedure: Corneal collagen crosslinking
The patients will be submitted to corneal collagen crosslinking, that consists: Instillation of riboflavin eyedrop in the cornea for thirty minutes, and after, the patient will stay under the Crosslinking equipment, for more thirty minutes, also receiving riboflavin eyedrop.
Other Names:
  • Keratoconus.
  • Corneal collagen crosslinking.
  • Active Comparator: Crosslinking

    The patients will be submitted to corneal collagen crosslinking, by use riboflavin eyedrop with UVA light.

    Procedure: Corneal collagen crosslinking
    The patients will be submitted to corneal collagen crosslinking, that consists: Instillation of riboflavin eyedrop in the cornea for thirty minutes, and after, the patient will stay under the Crosslinking equipment, for more thirty minutes, also receiving riboflavin eyedrop.
    Other Names:
  • Keratoconus.
  • Corneal collagen crosslinking.
  • Outcome Measures

    Primary Outcome Measures

    1. Refractive data, visual acuity, topography patterns, pachymetry measurements. [Two years]

    Secondary Outcome Measures

    1. Anterior segment tomography data, corneal biomechanics, impression cytology. [Two years]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Patients with keratoconus

    • Patients that aren't using contact lenses

    • Pachymetry more than 400Um

    • Best visual acuity less or equal 20/30

    Exclusion Criteria:
    • Ocular surgeries before

    • Other eye diseases

    • Corneal curvature more than 65 dioptres

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Federal University of São Paulo São Paulo Brazil 04038-000

    Sponsors and Collaborators

    • Federal University of São Paulo

    Investigators

    • Principal Investigator: Adimara C Renesto, MD, Federal University of São Paulo
    • Study Chair: Mauro S Campos, MD, Federal University of São Paulo
    • Study Chair: Marta F Sartori, MD, Federal University of São Paulo

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00832897
    Other Study ID Numbers:
    • 1915/07
    First Posted:
    Jan 30, 2009
    Last Update Posted:
    Jan 7, 2011
    Last Verified:
    Jan 1, 2011
    Keywords provided by , ,
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 7, 2011